294.83
price down icon0.26%   -0.76
after-market Handel nachbörslich: 292.22 -2.61 -0.89%
loading

Beone Medicines Ltd Adr Aktie (ONC) Neueste Nachrichten

pulisher
Jul 19, 2025

BeOne Medicines Ltd.Sponsored ADR (ONC) Surges 4.0%: Is This an Indication of Further Gains? - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week High Following Analyst Upgrade - Defense World

Jul 18, 2025
pulisher
Jul 17, 2025

Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire Inc.

Jul 17, 2025
pulisher
Jul 15, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap UpTime to Buy? - MarketBeat

Jul 15, 2025
pulisher
Jul 14, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in Stock - Defense World

Jul 14, 2025
pulisher
Jul 08, 2025

BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 08, 2025
pulisher
Jun 30, 2025

BeOne Medicines (NASDAQ:ONC) Shares Gap DownShould You Sell? - MarketBeat

Jun 30, 2025
pulisher
Jun 29, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% Following Insider Selling - MarketBeat

Jun 29, 2025
pulisher
Jun 28, 2025

BeOne Medicines (NASDAQ:ONC) Receives “Outperform” Rating from Royal Bank Of Canada - Defense World

Jun 28, 2025
pulisher
Jun 28, 2025

Insider Selling: BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) COO Sells 1,363 Shares of Stock - MarketBeat

Jun 28, 2025
pulisher
Jun 27, 2025

BeOne Medicines (NASDAQ:ONC) Shares Down 3.6% After Insider Selling - Defense World

Jun 27, 2025
pulisher
Jun 17, 2025

BeOne Medicines (NASDAQ:ONC) Stock Price Down 5.4%Here's What Happened - MarketBeat

Jun 17, 2025
pulisher
Jun 13, 2025

Entergy Corp’s Shares Reel: 0.54% Quarterly Revenue Decline Amid 35.88B Market Cap - investchronicle.com

Jun 13, 2025
pulisher
Jun 13, 2025

BeOne Medicines Ltd ADR (ONC) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 13, 2025
pulisher
Jun 05, 2025

Cancer Stock Vaults 40% As Clinical Trial Shows 'Promise'; Sales Reach $1 Billion, Earnings To Triple - Investor's Business Daily

Jun 05, 2025
pulisher
Jun 03, 2025

LLY Stock Quote Price and Forecast - CNN

Jun 03, 2025
pulisher
Jun 02, 2025

H.C. Wainwright maintains neutral rating on Zymeworks stock - Investing.com India

Jun 02, 2025
pulisher
May 31, 2025

China approves novel HER2-targeted therapy for BTC By Investing.com - Investing.com South Africa

May 31, 2025
pulisher
May 30, 2025

Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge By Stocktwits - Investing.com India

May 30, 2025
pulisher
May 30, 2025

China approves novel HER2-targeted therapy for BTC - Investing.com Australia

May 30, 2025
pulisher
May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland - Investing.com

May 27, 2025
pulisher
May 27, 2025

BeiGene completes corporate re-domiciliation to Switzerland By Investing.com - Investing.com Nigeria

May 27, 2025
pulisher
May 26, 2025

Daiwa Raises BEIGENE's TP to HKD180; Brukinsa Sales Growth Outpaces Competitors - AASTOCKS.com

May 26, 2025
pulisher
May 21, 2025

BeiGene Shareholders Approve Director Elections and Auditors By Investing.com - Investing.com India

May 21, 2025
pulisher
May 13, 2025

Daiwa Sees Limited Upside for HSI, Prefers HK Stocks w/ Tech Trading Opportunities Like BEIGENE - AASTOCKS.com

May 13, 2025
pulisher
May 08, 2025

Market Momentum: BeiGene Ltd. ADR (ONC) Registers a -3.93 Decrease, Closing at 232.25 - DWinneX

May 08, 2025
pulisher
May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates - Investing.com

May 07, 2025
pulisher
May 07, 2025

BeiGene shares tumble over 5% as Q1 revenue misses estimates By Investing.com - Investing.com South Africa

May 07, 2025
pulisher
Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

BeiGene wins patent challenge against Pharmacyclics - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

BeiGene wins US patent dispute over cancer drug By Investing.com - Investing.com India

Apr 29, 2025
pulisher
Apr 29, 2025

Universal Health Q1 Earnings Beat on Strong Acute Care Admissions - Zacks Investment Research

Apr 29, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

BeiGene reports financial results under PRC GAAP - Investing.com

Apr 28, 2025
pulisher
Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025
pulisher
Apr 24, 2025

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance

Apr 24, 2025
pulisher
Apr 21, 2025

BigBear.ai Holdings Inc (BBAI) gets rating Downgrade from Northland Capital - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

Morgan Stanley analysts upgrades an Equal-weight rating for Urban Edge Properties (UE) - knoxdaily.com

Apr 21, 2025
pulisher
Apr 21, 2025

RBC Capital Mkts initates BeiGene Ltd. ADR (ONC) rating to an Outperform - knoxdaily.com

Apr 21, 2025
pulisher
Apr 17, 2025

BGNE Page Not Found - Benzinga

Apr 17, 2025
$575.42
price up icon 0.73%
$114.60
price up icon 2.84%
$325.64
price up icon 0.11%
$28.01
price up icon 5.54%
$103.44
price up icon 0.51%
Kapitalisierung:     |  Volumen (24h):